Trent G. Kamke - 26 Feb 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: Senior V. P., Operations
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol: LMAT
Transactions as of: 26 Feb 2026
Net transactions value: -$125,716
Form type: 4
Filing time: 02 Mar 2026, 21:01:56 UTC
Previous filing: 12 Jan 2026
Next filing: 13 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kamke Trent G	Senior V. P., Operations	C/O LEMAITRE VASCULAR , INC., 63 SECOND AVENUE, BURLINGTON	/s/ Laurie A. Churchill, Attorney-in-fact	02 Mar 2026	0001365739

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LMAT	Common Stock	Award	$0	+1,051	+16%	$0.000000	7,812	26 Feb 2026	Direct	F1
transaction	LMAT	Common Stock	Options Exercise	$0	+2	+0.03%	$0.000000	7,814	26 Feb 2026	Direct	F2
transaction	LMAT	Common Stock	Tax liability	$10,573	-93	-1.2%	$113.69	7,721	26 Feb 2026	Direct	F3
transaction	LMAT	Common Stock	Sale	$115,143	-1,044	-14%	$110.29	6,677	27 Feb 2026	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Dividend Equivalent Rights	Options Exercise	$0	-2	-23%	$0.000000	7	26 Feb 2026	Common Stock	2		Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next three years.
F2	Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F3	These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on December 6, 2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F4	These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.